Comparison of GomutraTriphala Vati and Tab Atorvastatin in Sthaulya(Obesity and Hyperlipidemia)

Not yet recruiting

Conditions: Obesity due to excess calories. Ayurveda Condition: MEDOVRUDDHIH,

Brief Summary: Being overweight iscommon problem of todays era. It is also associated most of the times with lipid level changes due to unhealthy habits such as sedentary life style,eating junk food,lack of exercise, stress.People are generally considered obese when BMI is above 25 kg/m2 and Hyperlipidemia is when Serum Cholesterol level is more than 200 mg/dl and Serum Triglyceride level more than 150 mg/dl.According to WHO overweight and obese are among leading causes of death globally.According to Ayurveda Medovruddhi especially in Sthaulya is mainly due to Meda and Kapha dushti.Therefore medoghna and kaphaghna properties of the drug will be used for treatment of Medovruddhi in Sthaulya. The main objective of this research work is to provide consolidated report on uses of properties of GomutraTriphala Vati and Tab.Atorvastatin in the management of Medovruddhi in Sthaulya with special reference to Hyperlipidemia.

Recruitment & Eligibility

Inclusion Criteria

1Patients suffering from Medovruddhijanit symptoms in Sthaulya.
2Patients who are having two or more following symptoms will be included for the study 1 SHWASADHIKYA 2 NIDRADHIKYA 3 AAYAS AKSHAMATA 4 JADDYA 5 BALAHEENATA 6 ATI KSHUDHA 7 ATI TRUSHNA 3Age group having 25 to 65 years age,irrespective of any gender,socio economic status and religion.
4B.M.I 25.0 to 35 kg/m2.
5Patient having Serum Total Cholesterol Level more than 200mg/dl 6Patient having Serum Triglyceride Level more than 150mg/dl.

Exclusion Criteria

1Pregnant and Lactating women.
2Known cases of Uncontrolled Diabetes Mellitus with Its Complications.
3Known cases of Major systemic diseases such as TB,AIDS,IHD,CA,Renal and Cerebral diseases.
4Known cases of Acute complications like Coronary Heart Disease,Hepatitis.
5High risk (above 65 yrs age,known cases of HTN,DM,COPD) 6Comorbid patients Suspected for Covid-19.
Suspected Covid-19 patients having symptoms as per ICMR guidelines.

Primary Outcome Measures

Name	Time	Method
To compare the efficacy of GomutraTriphala Vati 500 mg twice a day before meal with lukewarm water with Tab.Atorvastatin 10 mg once a day at night with water in Medovruddhi in Sthaulya with special reference to Hyperlipidemia within 60 days	60 days with follow up on 15th,30th,45th,60th day

Secondary Outcome Measures

Name	Time	Method
1.To compare and study the efficacy of GomutraTriphala Vati.	2.To compare and study the efficacy of Tab.Atorvastatin

Locations (1): Ayurved Rugnalay and Sterling Multispeciality Hospital,Nigdi,Pune
🇮🇳
Pune, MAHARASHTRA, India
Ayurved Rugnalay and Sterling Multispeciality Hospital,Nigdi,Pune
🇮🇳Pune, MAHARASHTRA, India
Dr Gargi Sanjay Limaye
Principal investigator
9405929955
gargilimaye089@gmail.com